| Name | TRAF3 interacting protein 2 |
| Description | This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene. [provided by RefSeq, Aug 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTRAF3IP2, also known as Act1 or CIKS, is an essential adaptor protein that mediates signaling downstream of the interleukin‐17 (IL‑17) receptor. It recruits key signaling partners—most notably TRAF6—to trigger activation of NF‑κB, MAPK, and AP‑1 pathways. TRAF3IP2 possesses U‑box E3 ubiquitin ligase activity that facilitates lysine‑63–linked ubiquitination of TRAF6, an event critical for propagating IL‑17–dependent inflammatory signals. Its function is precisely regulated by phosphorylation events mediated by kinases such as IKKi and TBK1, which can alter its interactions with TRAF6 and also promote its degradation via SCF‑β‑TrCP complexes to desensitize prolonged receptor stimulation. This central role in IL‑17 signaling—as well as the dual capacity to regulate both adaptive and innate immune responses—is underscored by studies in epithelial, airway, and neural cell types, where TRAF3IP2 modulates both defense responses and inflammatory mediator expression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic variants and altered splicing of TRAF3IP2 have been strongly linked to susceptibility to a number of autoimmune and inflammatory disorders—including psoriasis, psoriatic arthritis, systemic lupus erythematosus, and rheumatoid arthritis—and influence the balance of Th17 responses. Specific missense mutations (for example, the D10N variant) impair normal binding to TRAF6 and thereby alter downstream signaling, leading to dysregulated cytokine production and immune cell differentiation. In addition, studies have demonstrated that TRAF3IP2 mutations impact epithelial barrier functions and keratinocyte defense, as well as contribute to adverse drug reactions such as Stevens–Johnson syndrome, highlighting the broad clinical relevance of TRAF3IP2 in both innate and adaptive immunity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical role in IL‑17 receptor signaling, emerging evidence implicates TRAF3IP2 in diverse pathological processes including vascular remodeling, oncogenic fusion events, and aberrant tissue repair. For instance, TRAF3IP2–dependent signaling underlies aldosterone-induced cardiomyocyte hypertrophy and smooth muscle cell migration via MMP activation, while fusion transcripts involving TRAF3IP2 in lymphoid malignancies highlight its potential contribution to T‑cell receptor pathway deregulation. Additionally, modulation of TRAF3IP2 function by microRNAs and its involvement in retinal capillary degeneration, keloid formation, and possibly glioblastoma underscore its multifaceted roles across different tissues. These diverse findings not only expand the spectrum of TRAF3IP2’s biological functions but also position it as a promising therapeutic target in a range of diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Youcun Qian, Zhendong Zhao, Zhengfan Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.142294499"}], "href": "https://doi.org/10.1073/pnas.142294499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12089335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12089335"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Claudio Mauro, Pasquale Vito, Stefano Mellone, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of the adaptor protein CIKS in the activation of the IKK complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0006-291x(03)01532-8"}], "href": "https://doi.org/10.1016/s0006-291x(03"}, {"type": "t", "text": "01532-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12943667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12943667"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Fei Huang, Cheng-Yuan Kao, Shinichiro Wachi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.179.10.6504"}], "href": "https://doi.org/10.4049/jimmunol.179.10.6504"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17982039"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17982039"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiaoxia Li "}, {"type": "b", "children": [{"type": "t", "text": "Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cytokine (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cyto.2007.09.015"}], "href": "https://doi.org/10.1016/j.cyto.2007.09.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18061473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18061473"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Caini Liu, Wen Qian, Youcun Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Act1, a U-box E3 ubiquitin ligase for IL-17 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2000382"}], "href": "https://doi.org/10.1126/scisignal.2000382"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19825828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19825828"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ulrike Hüffmeier, Steffen Uebe, Arif B Ekici, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.688"}], "href": "https://doi.org/10.1038/ng.688"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20953186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20953186"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Eva Ellinghaus, David Ellinghaus, Philip E Stuart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.689"}], "href": "https://doi.org/10.1038/ng.689"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20953188"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20953188"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Amy Strange, Francesca Capon, Chris C A Spencer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.694"}], "href": "https://doi.org/10.1038/ng.694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20953190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20953190"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Peiqing Shi, Shu Zhu, Yingying Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2001653"}], "href": "https://doi.org/10.1126/scisignal.2001653"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22045853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22045853"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Cinzia Ciccacci, Livia Biancone, Davide Di Fusco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Crohns Colitis (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.crohns.2012.02.020"}], "href": "https://doi.org/10.1016/j.crohns.2012.02.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22445837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22445837"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Beate Böhm, Harald Burkhardt, Steffen Uebe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Res Ther (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/ar3807"}], "href": "https://doi.org/10.1186/ar3807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22513239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22513239"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Søren Ulrik Sønder, Andrea Paun, Hye-Lin Ha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1103233"}], "href": "https://doi.org/10.4049/jimmunol.1103233"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22581863"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22581863"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Fangfang Qu, Hanchao Gao, Shu Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00268-12"}], "href": "https://doi.org/10.1128/MCB.00268-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22851696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22851696"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Carlo Perricone, Cinzia Ciccacci, Fulvia Ceccarelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunogenetics (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00251-013-0717-6"}], "href": "https://doi.org/10.1007/s00251-013-0717-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23836313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23836313"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Fang Lv, Li-Jun Song, Xiu-Hua Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of Act1, a NF-κB-activating protein, in IL-6 and IL-8 levels induced by IL-17 stimulation in SW982 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharm Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/13880209.2013.798668"}], "href": "https://doi.org/10.3109/13880209.2013.798668"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23862741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23862741"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Bertrand Boisson, Chenhui Wang, Vincent Pedergnana, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.immuni.2013.09.002"}], "href": "https://doi.org/10.1016/j.immuni.2013.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24120361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24120361"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Anthony J Valente, Anand M Irimpen, Ulrich Siebenlist, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2014.02.014"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2014.02.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24561578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24561578"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Nimmisha Govind, Ananyo Choudhury, Bridget Hodkinson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2119/molmed.2014.00097"}], "href": "https://doi.org/10.2119/molmed.2014.00097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25014791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25014791"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Cinzia Ciccacci, Sara Rufini, Sandro Mancinelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms16035830"}], "href": "https://doi.org/10.3390/ijms16035830"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25775161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25775161"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Tim Wyant, Jose Estevam, Lili Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development and validation of receptor occupancy pharmacodynamic assays used in the clinical development of the monoclonal antibody vedolizumab."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cytometry B Clin Cytom (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cyto.b.21236"}], "href": "https://doi.org/10.1002/cyto.b.21236"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25908521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25908521"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Naveen K Somanna, Manjunath Yariswamy, Joseph M Garagliano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2015.07.001"}], "href": "https://doi.org/10.1016/j.cellsig.2015.07.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26148936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26148936"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Qun Wan, Zhuo Zhou, Shiping Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Interferon Cytokine Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/jir.2014.0146"}], "href": "https://doi.org/10.1089/jir.2014.0146"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26376209"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26376209"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Paola Conigliaro, Cinzia Ciccacci, Cristina Politi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0169956"}], "href": "https://doi.org/10.1371/journal.pone.0169956"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28107378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28107378"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Sylviane Lambert, William R Swindell, Lam C Tsoi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jid.2016.12.032"}], "href": "https://doi.org/10.1016/j.jid.2016.12.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28274739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28274739"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Sirisha Asuri, Sarah McIntosh, Valerie Taylor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Primary Biliary Cholangitis in British Columbia First Nations: Clinical features and discovery of novel genetic susceptibility loci."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.13686"}], "href": "https://doi.org/10.1111/liv.13686"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29297981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29297981"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Joanne Nititham, Calum Fergusson, Colin Palmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Candidate long-range regulatory sites acting on the IL17 pathway genes TRAF3IP2 and IL17RA are associated with psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/exd.13761"}], "href": "https://doi.org/10.1111/exd.13761"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30076642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30076642"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Sylviane Lambert, Caely A Hambro, Andrew Johnston, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jid.2018.11.021"}], "href": "https://doi.org/10.1016/j.jid.2018.11.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30528823"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30528823"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Srinivas Mummidi, Nitin A Das, Andrea J Carpenter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28792"}], "href": "https://doi.org/10.1002/jcp.28792"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31074012"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31074012"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Sarah I Lindstrom, Sigrun Sigurdardottir, Thomas E Zapadka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Diabetes Complications (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jdiacomp.2019.05.016"}], "href": "https://doi.org/10.1016/j.jdiacomp.2019.05.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31239234"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31239234"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Sagar Bhattad, Chitra Dinakar, Haneesha Pinnamaraju, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Immunol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10875-019-00664-x"}], "href": "https://doi.org/10.1007/s10875-019-00664-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31292894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31292894"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Georges Nemer, Nehme El-Hachem, Edward Eid, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cge.13767"}], "href": "https://doi.org/10.1111/cge.13767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32350852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32350852"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Levi H Jales Neto, Zofia Wicik, Georgea H F Torres, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of SNTG2, TRAF3IP2, and ITGA6 transcripts is associated with osteoporotic vertebral fracture in elderly women from community."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Genomic Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mgg3.1391"}], "href": "https://doi.org/10.1002/mgg3.1391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32602654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32602654"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Koen Debackere, Lukas Marcelis, Sofie Demeyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-24037-4"}], "href": "https://doi.org/10.1038/s41467-021-24037-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34140493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34140493"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Qiaoyu Yan, Bin Li "}, {"type": "b", "children": [{"type": "t", "text": "TRAF3IP2 regulated by FOXO4 affects fibroblast proliferation, migration, and extracellular matrix deposition in keloid through the TGF-β1/Smad pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cosmet Dermatol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jocd.15009"}], "href": "https://doi.org/10.1111/jocd.15009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35441794"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35441794"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Jingru Che, Thomas J DePalma, Hemamylammal Sivakumar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotechnol Bioeng (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/bit.28313"}], "href": "https://doi.org/10.1002/bit.28313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36544242"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36544242"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Shunyi Wang, Yihe Kuai, Simin Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12916-023-02791-0"}], "href": "https://doi.org/10.1186/s12916-023-02791-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36978108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36978108"}]}]}]}
|
| Synonyms | C6ORF6, C6ORF5, ACT1, C6ORF4, CIKS, CANDF8, PSORS13, C6ORF2 |
| Proteins | CIKS_HUMAN |
| NCBI Gene ID | 10758 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TRAF3IP2 has 6,434 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 127 datasets.
Click the + buttons to view associations for TRAF3IP2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TRAF3IP2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TRAF3IP2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TRAF3IP2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TRAF3IP2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TRAF3IP2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TRAF3IP2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TRAF3IP2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TRAF3IP2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TRAF3IP2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with TRAF3IP2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TRAF3IP2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TRAF3IP2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TRAF3IP2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TRAF3IP2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with TRAF3IP2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing TRAF3IP2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TRAF3IP2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TRAF3IP2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing TRAF3IP2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing TRAF3IP2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TRAF3IP2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TRAF3IP2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TRAF3IP2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TRAF3IP2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with TRAF3IP2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with TRAF3IP2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TRAF3IP2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TRAF3IP2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving TRAF3IP2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving TRAF3IP2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with TRAF3IP2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TRAF3IP2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TRAF3IP2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TRAF3IP2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TRAF3IP2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TRAF3IP2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TRAF3IP2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TRAF3IP2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TRAF3IP2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TRAF3IP2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TRAF3IP2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TRAF3IP2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TRAF3IP2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TRAF3IP2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TRAF3IP2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TRAF3IP2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TRAF3IP2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TRAF3IP2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TRAF3IP2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding TRAF3IP2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TRAF3IP2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TRAF3IP2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TRAF3IP2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TRAF3IP2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing TRAF3IP2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing TRAF3IP2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TRAF3IP2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TRAF3IP2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TRAF3IP2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TRAF3IP2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TRAF3IP2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TRAF3IP2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TRAF3IP2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TRAF3IP2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TRAF3IP2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TRAF3IP2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TRAF3IP2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TRAF3IP2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TRAF3IP2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with TRAF3IP2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TRAF3IP2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TRAF3IP2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TRAF3IP2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TRAF3IP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TRAF3IP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TRAF3IP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving TRAF3IP2 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate TRAF3IP2 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TRAF3IP2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TRAF3IP2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TRAF3IP2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TRAF3IP2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TRAF3IP2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TRAF3IP2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TRAF3IP2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TRAF3IP2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TRAF3IP2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TRAF3IP2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TRAF3IP2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TRAF3IP2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TRAF3IP2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TRAF3IP2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TRAF3IP2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with TRAF3IP2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TRAF3IP2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TRAF3IP2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TRAF3IP2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TRAF3IP2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TRAF3IP2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with TRAF3IP2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate TRAF3IP2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TRAF3IP2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TRAF3IP2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TRAF3IP2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TRAF3IP2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TRAF3IP2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TRAF3IP2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TRAF3IP2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TRAF3IP2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of TRAF3IP2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TRAF3IP2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TRAF3IP2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TRAF3IP2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TRAF3IP2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TRAF3IP2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TRAF3IP2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TRAF3IP2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TRAF3IP2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TRAF3IP2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TRAF3IP2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TRAF3IP2 protein from the WikiPathways Pathways 2024 dataset. | |